Considering the extensive involvement of SR-B1 in the various modifiable risk factors of stroke, there is likelihood that the net effect of SR-B1 activation may favor the prevention/treatment of stroke (Fig. 1). This evidence concerns the gene SCARB1 and stroke disorder.